Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
iron hydroxide adipate (1 trial)
Iron-Magnesium Hydroxycarbonate (Fermagate) (4 trials)
lanthanum (1 trial)
sevelamer (renagel) (2 trials)
Hyperphosphatemia (Phase 3)
Kidney Failure, Chronic (Phase 3)
Renal Insufficiency (Phase 3)
Trials (5 total)
Trial APIs (4 total)